Evidence map›Paper›PMID 39068010›Full record

ReviewGastroenterology clinics of North America2024

Update on Maintenance Immunosuppression in Intestinal Transplantation.

Satyajit Patwardhan, Julie Hong, Joshua Weiner

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Gastroenterology clinics of North America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trending ileal microbiome dysbiosis over time as an early assessment of intestinal transplant rejection risk.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Satyajit PatwardhanColumbia Center for Translational Immunology, 650 West 168th Street, BB1705, New York, NY 10032, USA.
Julie HongColumbia Center for Translational Immunology, 650 West 168th Street, BB1705, New York, NY 10032, USA.
Joshua WeinerColumbia Center for Translational Immunology, 650 West 168th Street, BB1705, New York, NY 10032, USA; Division of Abdominal Organ Transplantation, Columbia University Irving Medical Center, 622 West 168th Street, PH14-105, New York, NY 10032, USA. Electronic address: jiw2106@cumc.columbia.edu.

Funding

Training in Translational Immunology ResearchT32AI148099 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SYKES, MEGAN · 2020 to 2024
$1.4M
Defining the relationship between host-microbiome interactions and rejection after intestinal transplantationK23AI156026 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WEINER, JOSHUA · 2021 to 2025
$962k
NIAID NIH HHS K23 AI156026NIAID NIH HHS T32 AI148099
6 · The paper itself

Abstract

Outcomes in intestinal transplantation remain hampered by higher rates of rejection than any other solid organs. However, maintenance immunosuppression regimens have largely remained unchanged despite advances in therapies for induction and treatment of rejection and graft-versus-host disease. Recently, there have been a small number of new maintenance therapies attempted, and older agents have been used in new ways to achieve better outcomes. The authors herein review the traditional maintenance therapies and their mechanisms and then consider updates in new therapies and new ways of using old therapies for maintenance immunosuppression after intestinal transplantation.

Indexed as

Graft RejectionImmunosuppression TherapyImmunosuppressive AgentsIntestinesGraft vs Host DiseaseHumansImmunosuppressive AgentsIntestinal transplantationMaintenance immunosuppressionVedolizumab

Identifiers

PMID39068010
PMCPMC11284276

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.